Soltamox Related Clinical Trials
ITA - Clinical Study Comparing ARIMIDEXâ„¢ With NOLVADEXâ„¢ in Women With Breast Cancer Treated With NOLVADEX for at Least 2 Years [Active, not recruiting]
Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study [Completed]
Casodex - Nolvadex Combination [Completed]
Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women. [Active, not recruiting]
Randomized Study Comparing Tamoxifen Vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-Positive Patients [Completed]
Study Assessing Efficacy of ZARNESTRAâ„¢ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer [Terminated]
Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid [Active, not recruiting]
Cognition in the Study of Tamoxifen and Raloxifene [Completed]
A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer [Completed]
A Study of the TAXUS Liberté Stent for the Treatment of Long De Novo Coronary Artery Lesions [Completed]
ABCSG 8 - Adjuvant Treatment in Patients With Hormone Receptor-Positive Breast Cancer With Good to Moderate Differentiation. [Completed]
Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast Cancer [Active, not recruiting]
Prolonged Tamoxifen Compared With Shorter Tamoxifen in Treating Patients Who Have Breast Cancer [Active, not recruiting]
Trial of ZD1839 (Iressa) and Tamoxifen in Breast Cancer Patients [Active, not recruiting]
Examination of Tamoxifen in Acute Mania in Patients With Bipolar I Disorder [Completed]
Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer [Active, not recruiting]
Liver Safety Under Upfront Arimidex vs Tamoxifen [Recruiting]
Cognitive Aging - STAR [Completed]
Tamoxifen Pharmacogenetics and Clinical Effects [Completed]
Tamoxifen in the Prevention of Breast Cancer in Hodgkin's Disease Survivors [Active, not recruiting]
Tamoxifen-MRI Study [Completed]
Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen [Recruiting]
Prednisone Versus Tamoxifen in Idiopathic Retroperitoneal Fibrosis [Active, not recruiting]
Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment [Recruiting]
Tamoxifen for Progressive Transitional Cell Carcinoma Following Previous Chemotherapy Treatment [Recruiting]
Tamoxifen in Treatment of Acute Mania [Completed]
Exemestane As Treatment In Adjuvant For Post-Menopausal Patients With Non-Metastatic Breast Cancer [Active, not recruiting]
German Preoperative Adriamycin Docetaxel Study [Completed]
Fourteen Day Safety of Low-Dose Tamoxifen in Patients With Chronic Hepatitis C Who Have Failed Standard Medical Therapy [Not yet recruiting]
Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stents to Treat De Novo Coronary Lesions [Active, not recruiting]
Studying Blood Samples From Women With Breast Cancer or Ductal Carcinoma In Situ Who Are Receiving Tamoxifen [Not yet recruiting]
Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline [Recruiting]
CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen [Recruiting]
Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer
A Phase I Study of OncoLAR® (Registered Trademark) (NSC 685403) With/Without Tamoxifen in Patients With Osteosarcoma [Completed]
Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-Positive Patients [Completed]
Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer [Completed]
PROACT - Pre-Operative Arimidex Compared To Tamoxifen [Completed]
Tamoxifen in Treating Patients With Primary Liver Cancer [Active, not recruiting]
Radiation Therapy and Tamoxifen in Treating Children With Newly Diagnosed Brain Stem Glioma [Active, not recruiting]
Tamoxifen in Treating Women With Breast Cancer [Active, not recruiting]
Study Of MK-0752 In Combination With Tamoxifen Or Letrozole to Treat Early Stage Breast Cancer [Recruiting]
Randomized Phase III Study of Exemestane (Aromasin) for 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed by Exemestane [Not yet recruiting]
Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors [Completed]
Tipifarnib Plus Tamoxifen in Treating Women With Metastatic Breast Cancer [Completed]
Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer [Active, not recruiting]
Tamoxifen for the Prevention of Breast Cancer in High-Risk Women [Active, not recruiting]
Tamoxifen to Prevent Bone Loss and Heart Disease in Premenopausal Women Receiving Chemotherapy for Stage I or Stage II Breast Cancer [Active, not recruiting]
Tamoxifen in Treating Women With High-Risk Breast Cancer
Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer [No longer recruiting]
Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast Cancer [Withdrawn]
Effect of Tamoxifen on Breast Density in Premenopausal Women With Breast Cancer or High Risk for Breast Cancer [Completed]
Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer [Active, not recruiting]
Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Breast Cancer [Active, not recruiting]
Lapatinib and Tamoxifen in Treating Patients With Advanced or Metastatic Breast Cancer [Recruiting]
Tamoxifen Compared With Clomiphene Citrate for Women Who Had Thin Endometrium Women Under Clomiphene in a Previous Cycle [Recruiting]
Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer [Active, not recruiting]
Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer [Recruiting]
Tamoxifen Therapy in Amyotrophic Lateral Sclerosis [ALS] [No longer recruiting]
Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer. [Completed]
Evaluation of the Association Between CYP2D6 Genetic Polymorphisms and the Treatment Effect of Tamoxifen [Recruiting]
Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone Receptor-Positive Breast Cancer [No longer recruiting]
Tamoxifen and Bortezomib in Treating Patients With Recurrent Gliomas [Recruiting]
Tamoxifen Pharmacokinetics and CYP2D6 Polymorphisms in Asian Women With Hormone Receptor Positive Breast Cancer [Recruiting]
Two Different Regimens of Nolvadex in Preventing Gynecomastia Induced by Casodex 150 Mg in Patients With Prostate Cancer [Active, not recruiting]
Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor [Recruiting]
Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ [Recruiting]
Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma [Recruiting]
Sorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III Melanoma [Recruiting]
Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas [Recruiting]
A Phase II Study of ZD1839 and Tamoxifen in Patients With Epithelial Ovarian Carcinoma, Cancer of the Fallopian Tube or the Peritoneum Refractory to Platinum- and Taxane-Based Therapy [Completed]
Study of Anastrozole, Letrozole, or Exemestane With or Without Tamoxifen in Treating Postmenopausal Women With Hormone-Responsive Breast Cancer That Has Been Completely Removed By Surgery [Recruiting]
Tamoxifen in Treating Patients With Metastatic Bladder Cancer That Did Not Respond to Previous Chemotherapy [Recruiting]
Luteal v. Follicular Phase Surgical Oophorectomy & Tamoxifen in Premenopausal Women With Metastatic Hormone Receptor + Br. CA [Recruiting]
Fulvestrant or Tamoxifen in Treating Postmenopausal Women Who Are Undergoing Surgery for Ductal Carcinoma in Situ of the Breast [Active, not recruiting]
A Phase I Trial of Tamoxifen and 9-Cis-Retinoic Acid in Breast Cancer Patients [Completed]
Effect of Tamoxifen or an Aromatase Inhibitor on Estrogen Metabolism in Women Undergoing Treatment for Newly Diagnosed Breast Cancer [Recruiting]
Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer [No longer recruiting]
Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast Cancer [No longer recruiting]
Tamoxifen With or Without Combination Chemotherapy in Treating Postmenopausal Women With Operable Invasive Breast Cancer [No longer recruiting]
Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer [Active, not recruiting]
Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer [No longer recruiting]
Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer [No longer recruiting]
Epirubicin and Tamoxifen With or Without Docetaxel in Treating Postmenopausal Women With Breast Cancer [Active, not recruiting]
Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer [Completed]
Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer [No longer recruiting]
Ductal Lavage in Assessing Women With Early Breast Cancer or at High Risk of Developing Breast Cancer and Who Are Eligible For Tamoxifen Therapy [Completed]
Different Durations of Adjuvant Anastrozole Therapy After 2 to 3 Years Tamoxifen Therapy in Breast Cancer [Recruiting]
Medroxyprogesterone in Treating Women With Breast Cancer [Active, not recruiting]
Chemoprevention Therapy Plus Surgery in Treating Women With Breast Cancer [No longer recruiting]
Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer [Recruiting]
Temsirolimus With or Without Megestrol and Tamoxifen in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer [Recruiting]
Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG-2402 [Recruiting]
Arimidex Observational: Reason for and Effect of Change From Tamoxifen [No longer recruiting]
Tamoxifen Study [Completed]
Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in Situ [Recruiting]
Open-Label Study Of Exemestane With Or Without Celecoxib In Postmenopausal Women With ABC Having Progressed On Tamoxifen [Active, not recruiting]
A Study to Evaluate the Effect of Letrozole and Tamoxifen on Bone and Lipids in Postmenopausal Women With Breast Cancer [Completed]
Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen [Active, not recruiting]
Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole [Recruiting]
|
